Keyphrases
Parkinson's Disease
100%
Beta Power
100%
GABAergic Modulation
100%
Continuous Motion
100%
Bradykinesia
100%
Zolpidem
50%
Movement Task
50%
Time-based
25%
Magnetoencephalography
25%
Parkinson Patients
25%
Attenuation
25%
Oscillation
25%
Motor Cortex
25%
Placebo
25%
Functional Significance
25%
Therapeutic Target
25%
Placebo-controlled
25%
Control Design
25%
Primary Motor Cortex
25%
Beta Oscillations
25%
Post-movement beta Rebound
25%
Motor Symptoms
25%
Unified Parkinson's Disease Rating Scale (UPDRS)
25%
γ-aminobutyric Acid
25%
Motor Network
25%
Movement Speed
25%
Augmented Beta
25%
Functional Improvement
25%
Scale Measurement
25%
Discrete Movements
25%
Medicine and Dentistry
Parkinson's Disease
100%
Bradykinesia
100%
Placebo
50%
Zolpidem
50%
Magnetoencephalography
25%
Motor Cortex
25%
Gamma-Aminobutyric Acid
25%
Unified Parkinson's Disease Rating Scale
25%
Primary Motor Cortex
25%
Rebound
25%
Treatment of Parkinson's Disease
25%
Design Controls
25%
Neuroscience
Parkinson's Disease
100%
Bradykinesia
100%
Placebo
40%
Zolpidem
40%
Magnetoencephalography
20%
Motor Cortex
20%
Gamma-Aminobutyric Acid
20%
Primary Motor Cortex
20%
Treatment of Parkinson's Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Bradykinesia
100%
Placebo
33%
Zolpidem
33%
4 Aminobutyric Acid
16%